
Work Here?
Work Here?
Work Here?
Tandem Health streamlines clinical documentation by using AI to help healthcare providers write medical notes during patient visits. Clinicians can verbalize findings, and the AI automatically turns speech into structured notes without interrupting the consultation, freeing time for patient care. The service runs on a subscription basis for healthcare providers in Sweden, with all data encrypted and processed within Sweden to comply with EU rules. Aimed at reducing administrative workload, the solution supports more efficient workflows and better patient involvement in care. Compared to competitors, Tandem Health emphasizes data locality (Sweden-only processing), strong data privacy, and a seamless, non-disruptive note-taking experience, backed by leadership with healthcare and AI backgrounds. The goal is to cut documentation time, improve clinician efficiency, and advance healthcare practices through reliable, privacy-conscious AI tooling.
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$59.5M
Headquarters
Stockholms kommun, Sweden
Founded
2023
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$59.5M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Flexible Work Hours
Remote Work Options
Streets Heaver partners with Tandem Health to bring enterprise-grade Ambient AI documentation into compucare(r) Clinician Pro. By Holly Johnson, Marketing Executive Streets Heaver Healthcare Computing is pleased to announce a strategic partnership with Tandem Health, bringing enterprise-grade Ambient AI documentation directly into Compucare Clinician Pro. The integration will provide healthcare organisations with a fully embedded experience, enabling clinicians to capture consultations, generate structured clinical documentation and correspondence, and return approved outputs directly into the patient record, all without leaving Compucare. This partnership marks another significant milestone in Streets Heaver's AI strategy, complementing the company's native AI platform, NIVA, while reinforcing its commitment to delivering safe, governed and practical AI solutions for private healthcare providers and NHS Private Patient Units. As one of the UK's most widely adopted private healthcare management platforms, Compucare continues to evolve around the needs of clinicians, operational teams and healthcare leaders. This latest development reflects a clear focus on reducing administrative burden, improving workflow efficiency and supporting better patient care through intelligent technology. A native experience built for clinical workflows. Unlike standalone AI tools that operate separately from core clinical systems, the Tandem integration has been designed as a seamless part of the Compucare experience. Clinicians will be able to launch Tandem directly from within Compucare Clinician Pro. Patient and appointment context will flow through automatically, consultations will be captured and structured in real time, and approved documentation will return directly into the patient's record. The result is a more streamlined clinical workflow that reduces documentation burden while maintaining clinician oversight and control. Announcing the partnership, Benedict Heaver, CEO of Streets Heaver Healthcare Computing, said: "For its customers, this offers a native, embedded experience where clinicians launch Tandem directly from inside Compucare, consultations are captured and structured automatically, and approved output flows straight back into your patient record. Streets Heaver has spent months evaluating the Ambient AI landscape carefully. What set Tandem apart was not just the product, it was the alignment. They are MDR Class IIa certified for their Scribe & Coding Assistant, externally audited, and built for the enterprise private healthcare environment Streets Heaver serve. This will sit alongside its native AI, NIVA, which is already baked into its products and extends its AI vision, in a safe and transparent way. To its existing customers, Streets Heaver'll be in touch over the coming weeks to talk through what this means for you. To the wider market, this is building on its existing investments in AI across its platform in a way that's safe, governed and useful." Why Tandem Health? Founded in Stockholm, Tandem Health has emerged as one of Europe's leading Ambient AI healthcare companies, helping clinicians reduce documentation time through AI-powered clinical note generation and workflow support. The company's focus on clinical governance, compliance and healthcare-specific design closely aligns with Streets Heaver's approach to healthcare technology. Dr Katie Baker, GTM Director, UK & Ireland at Tandem Health, commented on the partnership: "What excites me about this partnership is that Compucare approached it the way we do - carefully, with governance front of mind. For healthcare organisations, that means AI documentation that's not just capable, but certified and enterprise-ready from day one." Over recent months, Streets Heaver undertook a detailed review of the Ambient AI market, assessing a range of solutions against the requirements of private healthcare organisations and NHS Private Patient Units. While functionality was an important consideration, governance, regulatory standards and long-term strategic fit were equally critical. Tandem stood out for three key reasons: * MDR Class IIa certification for its Scribe & Coding Assistant * An externally audited development and quality process * A commitment to deep platform integration rather than operating as a disconnected third-party application Andy Robinson, Head of Technology at Streets Heaver, explained: "The integration Streets Heaver is delivering isn't a bolt-on. Clinicians will launch Tandem directly from Compucare, patient and appointment context will flow through automatically, and approved notes and correspondence will return directly to the patient record. What made Tandem the right partner was the combination of MDR Class IIa certification, an externally audited build process and a genuine commitment to deep integration. They build the way Streets Heaver build: modular, deliberate and enterprise-first. Complementing this is its native AI, NIVA, already integrated into its products, helping to extend its AI vision while maintaining a strong focus on safety and transparency." Why Ambient AI matters now. The partnership reflects a broader shift in what clinicians expect from healthcare technology. Today's clinicians are accustomed to intuitive, consumer-grade experiences in their everyday lives. Increasingly, they expect the same simplicity and responsiveness from the systems they use at work. At the same time, healthcare organisations face growing documentation requirements, increasing administrative pressure and rising volumes of clinical data. The challenge is not simply digitising paper processes. The challenge is helping clinicians access the right information, at the right time, without introducing additional complexity into their workflows. Streets Heaver's Customer Success Manager, Mark Wilkinson, believes the integration addresses one of the biggest frustrations clinicians face during consultations: balancing documentation with patient interaction. "Tandem will be a big step forward for clinicians. Many are already using AI-powered dictation tools like Tandem to capture their assessment notes, but integrating that capability directly into Clinician Pro is the missing piece. Clinicians use dictation because they want to focus their full attention on the patient during consultations. Having to stop and write notes throughout the conversation is distracting, whereas this integration allows documentation to happen seamlessly without interrupting patient care." At Streets Heaver, this philosophy has shaped the development of Compucare Clinician Pro, where usability, workflow alignment and information relevance are central design priorities. As Candy Mussett, Head of Operations at Streets Heaver, explains: "Healthcare technology should feel like a natural extension of clinical practice. Clinicians need systems that are intuitive, reliable and designed around the way they actually work." Stuart Hymers, Head of Commercials, adds: "Technology works best when it's designed with clinicians, not for clinicians. The closer we align software to real-world clinical workflows, the more value it delivers." Ambient AI represents an important step in that journey. By reducing the time spent on documentation and administration, clinicians can focus more of their attention on patient interactions and clinical decision-making. Building on the Vision for AI at Streets Heaver. This partnership complements Streets Heaver's wider AI roadmap and ongoing investment in innovation across the Compucare platform. Alongside Tandem's Ambient AI capabilities, Streets Heaver continues to develop NIVA, its native AI platform designed to deliver intelligent assistance across healthcare workflows. The company's vision is clear: AI should support clinicians and operational teams by reducing complexity, surfacing relevant information and improving efficiency, while maintaining transparency, governance and human oversight. As healthcare organisations continue to generate increasing volumes of clinical and operational data, the opportunity for AI extends beyond documentation alone. Future innovation will focus on helping users access meaningful insights faster, identify trends more effectively and make better-informed decisions without increasing workload. The objective is not to replace clinical judgement. It is to support it. Looking ahead. Hosted Compucare customers will be among the first to benefit from the deep integration capabilities being introduced through the partnership. Over the coming weeks, Streets Heaver and Tandem Health will begin engaging with customers to demonstrate the technology, discuss implementation options and explore how Ambient AI can support different clinical environments. This partnership represents another step towards a future where healthcare technology becomes increasingly intuitive, intelligent and aligned to the realities of clinical practice. Book a demonstration. Book a personalised demonstration to discover how Compucare, Tandem Health and NIVA are helping healthcare organisations reduce administrative burden, improve clinician productivity and deliver more efficient patient care.
Tandem Health establishes its clinical AI hub in the Paris Region. March 27, 2026 Tandem Health, a Swedish healthtech company, is transforming clinical practice through an intelligent medical assistant that serves as a true co-pilot for clinicians. By listening to the consultation, transcribing it in real time, and generating a medical note that can be seamlessly integrated into the patient's record, the solution significantly reduces administrative workload. Fully compliant with GDPR and local data-protection standards, Tandem Health empowers healthcare professionals to regain valuable clinical time and focus on delivering high-quality care to their patients. Now established in the Paris Region, Tandem Health is expanding at the heart of one of Europe's most dynamic ecosystems for healthcare innovation and artificial intelligence. Working alongside leading institutions such as Hôpital Fondation Adolphe de Rothschild and Hôpital Foch, the company is accelerating the deployment of next-generation clinical tools and laying the foundations for long-term European growth. In this exclusive interview, Félix Motosso, Managing Director France at Tandem Health, shares the company's vision, the transformative role of AI in modern clinical workflows, and why the Paris Region offers a strategic environment for their expansion. To begin, could you briefly introduce Tandem Health and your role within the organization? Tandem Health is a European company developing an AI-powered medical assistant designed to act as a true co-pilot for healthcare professionals. Its solution automates clinical documentation, generates consultation summaries, and simplifies administrative tasks related to patient records. The goal is simple: give clinicians the ability to spend less time on paperwork and spend more time with their patients. Today, its technology is used by more than a thousand healthcare institutions across Europe. As Managing Director in France, my role is to develop Tandem Health's presence in the French market, collaborate with partner hospitals and clinics, and support the adoption of AI within clinical practice. How is your AI assistant transforming the daily work of healthcare professionals? A significant share of medical time is spent on administrative tasks: writing consultation notes, updating patient files, or coding procedures. In some cases, this accounts for nearly one-third of a physician's working time. Its AI assistant automates much of this workload. During a consultation, it can transcribe the exchange between physician and patient, automatically generate a structured clinical note, and suggest coding or documentation elements. In practice, this dramatically reduces the time clinicians spend on documentation. In some deployments, healthcare professionals recover up to two hours per day, which they can reinvest in patient care. Its vision is very clear: AI does not replace physicians, it supports them by giving back what they lack most today: clinical time. Yes, Parisregionimpact has launched several collaborations with healthcare institutions in France. These partnerships are essential to tailoring its technology to real-world clinical workflows and to the specific requirements of the French healthcare system. For instance, Hôpital Fondation Adolphe de Rothschild in Paris has integrated its AI assistant in several departments to experiment with automated clinical documentation and enhance the time dedicated to patient interaction. Parisregionimpact is also currently deploying its solution across the entire Hôpital Foch, and Parisregionimpact is finalizing agreements with several public hospitals, which Parisregionimpact will announce soon. These early deployments allow Parisregionimpact to work closely with clinical teams, refine use cases, validate the impact on care quality, and build solutions that truly address healthcare professionals' needs. What made the Paris Region the obvious strategic hub for Tandem Health's expansion in Europe? The Paris Region is one of Europe's leading hubs for healthcare innovation and artificial intelligence. It brings together an exceptional ecosystem of hospitals, startups, research institutes, and public stakeholders dedicated to transforming healthcare. For a company like Tandem Health, which develops AI solutions embedded directly in clinical workflows, this is an incredibly stimulating environment. It enables Parisregionimpact to collaborate with top-tier medical institutions, as well as with key technological and regulatory actors. Establishing its operations here aligns perfectly with its ambition to build a European clinical platform capable of supporting the needs of diverse healthcare systems across the continent. What makes France a particularly strategic and timely market for the adoption of ai-driven healthcare solutions? The French healthcare system is renowned for its quality, but it also faces significant challenges: expanding medical deserts, increasing administrative burden, and growing pressure on clinicians. These realities make France a strong market for technologies that improve workflow efficiency. A considerable portion of physicians' time is still dedicated to non-medical tasks. AI has the potential to reduce this burden and enhance care coordination, while fully meeting the high standards of security and data protection required in France. You are a member of different initiatives in the Paris Region, such as future4care and medicen. How do these organizations support you on a daily basis? These organizations play a key role within the health innovation ecosystem. They create bridges between startups, hospitals, researchers, and industry leaders. For a company like ours, they offer valuable opportunities for collaboration, clinical experimentation, and dialogue with healthcare stakeholders. They also help Parisregionimpact better understand regulatory expectations and the realities of clinical practice in France. Are you planning to recruit specific profiles in the Paris Region? Yes. France is one of its priority markets for the coming years, and its rapid expansion across Europe is driving the growth of its local teams. Parisregionimpact is particularly looking for talent to support its expansion in the French market, including commercial profiles with healthcare experience, and clinical professionals to support its product development and deployment projects. How did choose Paris Region support you in your expansion journey in the region? Choose Paris Region played an important role in its local expansion. Their team supported Parisregionimpact on several fronts: understanding the ecosystem, connecting Parisregionimpact with institutional and industry partners, and assisting with practical aspects of its establishment. This type of support is especially valuable for an international company looking to enter a new market quickly and build a solid local network. What are the next steps for Tandem Health in France? Its priority is to continue deploying its technology across French healthcare institutions and to support clinicians in adopting these new tools. Parisregionimpact is also expanding the capabilities of its platform. Today, automated documentation is only the first layer. Its medical coding assistance module was recently certified as a Class 2a medical device, a first for the industry, and Parisregionimpact is developing solutions for care coordination and other key steps of the clinical workflow. Its ambition is to build a comprehensive AI-powered clinical platform that can support healthcare professionals at every stage of the patient journey. Based on your experience, what advice would you give to companies considering expanding into the Paris Region? The Paris Region offers an exceptional environment for technology companies, particularly in the healthcare sector. My main advice would be to integrate rapidly into the local ecosystem: meet healthcare institutions, innovation clusters, researchers, and public stakeholders. It is a demanding but incredibly dynamic market. For companies ready to collaborate closely with the healthcare system, it offers significant opportunities to develop and deploy innovation at scale. Choose Paris experts. Yann masson. Healthcare, Life Sciences
Tandem Health acquires Dutch AI scribe Juvoly, marking Europe’s first AI medical scribe acquisition and a move toward scalable, clinician-first, compliant AI documentation.
Dutch healthcare AI startup Juvoly has been acquired by Swedish company Tandem Health. Juvoly, which provides voice-controlled software for automatic reporting in healthcare, processes over 200,000 consultations monthly for more than 1,500 general practitioners across the Netherlands. The merger aims to achieve economies of scale and enable European expansion. Juvoly's technology, optimised for Dutch and Frisian medical terminology, reportedly reduces administration time by 40%. Juvoly will continue operating under the name Juvoly, powered by Tandem, maintaining its Dutch team and servers. The acquisition gives Juvoly access to additional development capacity, international knowledge and medical certification experience. In early 2025, Juvoly invested in the first Nvidia DGX B200 supercomputers in the Netherlands.
Spiich Labs raises €600k pre-seed for AI healthcare platform. European healthcare AI is experiencing a renaissance, driven by regulatory clarity from the AI Act and growing corporate adoption. Spiich Labs, a Stockholm-based startup developing AI-powered speech analysis for healthcare diagnostics, has secured €600k in pre-seed funding led by Tandem Health, with participation from Creandum founders and Ampli Ventures. The funding represents a strategic bet on the intersection of voice technology and healthcare, where European startups are carving out distinctive advantages through privacy-first approaches and regulatory compliance. AI healthcare funding attracts Nordic investors. Tandem Health's lead investment reflects the Swedish fund's thesis around digital health infrastructure that can scale across fragmented European markets. The participation of Creandum founders signals strong conviction from operators who previously backed Spotify and Klarna through similar early-stage dynamics. "Speech analysis represents an untapped diagnostic frontier where European companies can lead globally," noted a Tandem Health partner. "Spiich's approach to privacy-preserving voice biomarkers aligns perfectly with European regulatory frameworks whilst addressing genuine clinical needs." The investor mix combines healthcare-focused capital with generalist expertise, providing Spiich with both sector knowledge and scaling playbooks from Nordic success stories. Ampli Ventures' involvement adds operational depth to the round. Voice biomarkers target European healthcare systems. Spiich Labs is developing AI algorithms that analyse speech patterns to detect early indicators of neurological and respiratory conditions. The platform processes vocal biomarkers through machine learning models trained on European datasets, ensuring compliance with GDPR whilst building clinically relevant insights. The startup's go-to-market strategy focuses initially on Nordic healthcare systems, where digital health adoption rates exceed European averages and procurement processes favour innovative solutions. Early pilots with Swedish hospitals have demonstrated diagnostic accuracy improvements of 15-20% for certain respiratory conditions. "European healthcare systems need diagnostic tools that integrate seamlessly with existing workflows whilst maintaining patient privacy," explained the Spiich Labs CEO. "Our voice analysis platform delivers clinical insights without storing personal data, addressing two critical healthcare challenges simultaneously." Funding will accelerate product development and support expansion across the Nordics, with plans for broader European deployment by 2026. The company competes with US-based voice AI startups but differentiates through European regulatory compliance and healthcare system integration. This funding positions Spiich within Europe's growing voice technology ecosystem, where regulatory advantages and healthcare market access create defensible competitive moats. The pre-seed validates European investors' appetite for AI healthcare solutions that leverage continental strengths.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$59.5M
Headquarters
Stockholms kommun, Sweden
Founded
2023
Find jobs on Simplify and start your career today